Boehringer Ingelheim Vetmedica and Bayer announce agreement for purchase of U.S. Cydectin®
Bayer and BIVI announced an agreement under which, Bayer would acquire BIVI’s CYDECTIN bovine and ovine endectocide products in the U.S. The sale of BIVI’s U.S. CYDECTIN products is a required step toward BI’s acquisition of Merial as part of the larger swap transaction between Sanofi and BI. December 07, 2016